UNITED STATES
Media Center

AREVA Med - Nuclear Therapy

AREVA Med

AREVA Med is an AREVA subsidiary specializing in the development of innovative therapies to fight cancer. AREVA Med has developed new processes for producing high purity lead-212 (²¹²Pb), a rare radioactive isotope that is currently at the heart of promising nuclear medicine research.

This rare isotope is used in alpha radioimmunotherapy, a powerful anticancer therapy which offers great potential for combating certain very agressive types of cancer.